Organoid Models Derived from Primary Tumors and Patient-Derive Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients
Parisa Nikeghbal, Dorsa Zamanian, Danielle Burke, Mara P. Steinkamp
This study shows that organoids derived from patient-derived xenografts (PDXOs) reflect the chemotherapy response of ovarian cancer patients similarly to organoids directly from primary tumors (PDOs).
BMC Cancer · Sep 30, 2025Peer-reviewedCancer Biology